Canadians set to send more than 52 million parcels with Purolator this holiday season

Purolator expects to process 1.3 million pieces a day until Dec. 24, 2025 From Prince Rupert, B.C., to Whitehorse, Yukon, to Corner Brook, N.L., Purolator couriers have begun criss-crossing the nation as holiday shipping season kicks into high gear this week.Purolator, a leading Canadian integrated freight, package and logistics solutions provider, released its annual peak […]

AlphaTON Capital Submits Strategic Offer to Acquire Majority Stake in Forbes Media Holdings

(NASDAQ:ATON), New York, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital (Nasdaq: ATON), a specialized digital asset technology company focused on the Telegram ecosystem, today announced that it has submitted a Letter of Intent (LOI) to acquire a 51% controlling interest in Forbes Media Holdings (FMH). The proposed acquisition is part of AlphaTON's broader

Edify Engine Unveils Agency & Studio Solutions, Delivering Scalable 3D World Production for Professional Creative Teams

Wilmington, DE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Edify Engine, widely recognized as the “WordPress of 3D,” today announced the release of its new Agency & Studio Solutions — a major product expansion built for creative agencies, digital studios, enterprise teams, and large-scale production environments. The offering enables professional teams to design, launch, and manage

Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference

(NYSE MKT:CANF),(TASE:CFBI),(TASE:CANF.TA), Namodenoson, a Phase III cancer drug has strong potential in veterinary oncology, a market projected to reach $3.1 billion by 2030 Piclidenoson is currently in development for the treatment of osteoarthritis in pets; Clinical studies show efficacy in dogs, representing a $3 billion market RAMAT GAN, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) —

Upwind positioned as a Leader in the SPARK Matrix(TM): Cloud Native Application Protection Platform (CNAPP), 2025 by QKS Group

Pune, India, Nov. 24, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading CNAPP vendors. Upwind, with its comprehensive CNAPP solution, has received strong ratings across technology excellence and customer impact. QKS Group announced today that it has named Upwind as a leader in the SPARK Matrix(TM):

Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data

(NASDAQ:KTTA),(NASDAQ:KTTAW), — Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – –Cohort 7 Pharmacokinetic (PK) profile continues to demonstrate dose-proportionality and Cmax/Cmin ratio <2. Achieved exposures (AUC) of 6,690 ng– h/mL – — Pharmacodynamic (PD) data support continuous suppression of MAPK pathway throughout the 24-hour cycle – — Safety Review

DraftKings Set to Launch Mobile Sports Wagering in Missouri on December 1

(NASDAQ:DKNG), BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced plans to launch its top-rated mobile sportsbook in Missouri on December 1, 2025. Earlier this year, the Missouri Gaming Commission granted DraftKings a temporary direct mobile sports wagering license, allowing DraftKings to operate independently across the state without the need for

Mirasol Signs Definitive Agreement for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty

(TSX-V:MRZ),(Pinksheets:MRZLF),(PinkSheets:MRZLF), Ampere Metals to acquire up to 100% of the Virginia Project for a total cash consideration of US$ 8.0 million over 7 years of scheduled payments Mirasol will retain a 2% NSR Royalty with the unilateral right to sell to Ampere Metals for a minimum of US$ 2.0 million VANCOUVER, British Columbia, Nov. 24,

Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

(TSX-V:LOVE),(OTC US:LOVFF),(Other OTC:LOVFF),(Boerse Frankfurt – Freiverkehr:8CB0.F), Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million1, net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million1 for Fiscal 2025. Stronger Balance Sheet and Earnings Quality: First year of positive retained earnings

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

(NASDAQ:MCRB), CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 10:30 a.m. ET. A live webcast of the chat will be accessible through the

Scroll to Top